A study by Chen et al. [67] identified β-lactamase-like protein 2 (LACTB2) as a protein highly elevated in radioresistant NPC cells and in the serum of NPC patients postradiotherapy. This evidence concerns the gene LACTB2 and nasopharyngeal carcinoma.